Abstract | Originally described over a decade ago as a T cell transcription factor regulating T helper 1 cell lineage commitment, T-bet is now recognized as having an important role in many cells of the adaptive and innate immune system. T-bet has a fundamental role in coordinating type 1 immune responses by controlling a network of genetic programmes that regulate the development of certain immune cells and the effector functions of others. Many of these transcriptional networks are conserved across innate and adaptive immune cells and these shared mechanisms highlight the biological functions that are regulated by T-bet. REVIEWS NATURE REVIEWS | IMMUNOLOGY VOLUME 13 | NOVEMBER 2013 | 777
T-bet (encoded by Tbx21) is an immune cell-specific member of the T-box family of transcription factors (FIG. 1) . The adaptive immune system arose approximately 500 million years ago in jawed fish probably as a result of the emergence of the recombination-activating gene (RAG) transposon 1 . Prior to this event, primitive B cell-like and T cell-like cells could be identified in jawless fish, such as lampreys 2 . Intriguingly, a comparative evolutionary analysis indicates that the eomesodermin (EOMES), T-box brain protein 1 (TBR1) and T-bet subfamily of T-box genes arose very early in evolution before the appearance of classical adaptive immunity and can be identified in both lampreys (see ensembl database) and amphioxus 3 . Many of our current ideas about the key functions of T-bet derive from studies in T cells. The initial description of T-bet as a master regulator of commitment to the T helper 1 (T H 1) cell lineage as well as the elucidation of intersecting T cell transcriptional pathways has enabled rapid progress to be made in defining the genetic modules that control T cell polarity. However, it is possible that these regulatory pathways may have been coopted from more ancient cell types, especially as it is now appreciated that innate immune cells also express T-bet.
The effects of T-bet on the regulation of adaptive immune functions are well recognized and the molecular mechanisms have mostly been elucidated by analysing the genomic transcriptional targets in different cell types. Transcription factors activate or repress their target genes by binding to accessible promoter and enhancer elements. The development of methodologies to identify the direct genomic targets of T-bet has transformed our ability to dissect the intracellular pathways that regulate T cell differentiation. Chromatin immunoprecipitation (ChIP) coupled with array-based proximal promoter analysis (ChIP-chip) provided insight into the genes that are directly regulated by T-bet. The advent of massively parallel DNA sequencing (also known as ChIP-sequencing (ChIP-seq)) has more recently facilitated both greater resolution of promoter targets and insight into the distal enhancer elements that T-bet regulates 4, 5 . ChIP-seq data sets from other transcription factors, such as GATA-binding protein 3 (GATA3), retinoic acid receptor-related orphan receptor-γt (RORγt; encoded by Rorc) and signal transducer and activator of transcription 4 (STAT4), combined with knowledge of the chromatin architecture at specific loci, has increased the understanding of how these molecules interact to coordinate T cell function [4] [5] [6] [7] [8] [9] . Interestingly, it has recently been shown that T-bet binds to large domains that have clusters of enhancers associated with important T cell genes -known as 'super enhancers' -which are characteristics of master regulatory genes that define cell identity 10 . However, in most cases, it remains to be formally proven that these specific interactions take place at a single-cell level and that they do not reflect the heterogeneity within the cell populations studied. By contrast, much less is known about the range of T-bet target genes in primary innate immune cells because of the relatively large cell numbers that are required for these types of studies. However, many of the transcriptional pathways that have been defined in T cells are also relevant in innate immune cells, which indicates that considerable insights can be gained by investigating the parallel roles of T-bet in innate and adaptive immunity. In this Review, we discuss the shared transcriptional mechanisms that regulate the development and/or the effector functions of innate and adaptive immune cells. We review the role of T-bet in maintaining mucosal homeostasis through its action in dendritic cells (DCs) and innate lymphoid cells. Special emphasis is given to the role of T-bet in the biology of CD4 + T H cells. We discuss the intricate molecular mechanisms that are regulated by T-bet to promote T H 1 cell differentiation and to suppress the development of opposing T H cell lineages. In addition, we describe how T-bet expression 'tips the balance' in favour of terminal differentiation of CD4 + and CD8 + effector T cells at the expense of memory cell formation.
T-bet in the innate immune system T-bet in DCs. Much less is known about the function of T-bet in the innate immune system than is known about its function in T cells. T-bet was initially shown to be expressed in human monocytes and myeloid DCs after stimulation with interferon-γ (IFNγ) 11 . Loss-offunction studies indicated that, in the absence of T-bet, DCs were unable to efficiently prime T H 1 cell responses and they did not respond to the protective adjuvant activity of CpG DNA in vivo during Listeria spp. infection 12, 13 (FIG. 2) . T-bet was also shown to directly regulate inflammatory arthritis via its expression in DCs and by regulating T cell activation 14 . T-bet has more recently been recognized as being an important regulator of intestinal homeostasis 15 . T-bet expression in DCs was shown to regulate the homing of mast cell progenitors to mucosal tissue through the control of expression of mucosal addressin cell adhesion molecule 1 (MADCAM1) and vascular cell adhesion molecule 1 (VCAM1) 16 . However, despite a marked reduction in the number of mucosal mast cells, Tbx21 −/− mice were still able to vigorously respond to intestinal infection with Trichinella spiralis.
In order to focus solely on the role of T-bet in innate immunity, T-bet-deficient mice were crossed onto a Rag2 −/− background. Remarkably, mice deficient in both T-bet and RAG2 (Tbx21
Rag2
−/− mice) developed a spontaneous intestinal inflammation that resembled ulcerative colitis in humans 17 . Inflammation in this model was transmissible to T-bet-sufficient mice and was driven by a dysbiotic microbiota 17, 18 . The model became known as the TRUC (Tbx21
−/− ulcerative colitis) mouse model and has proved useful in uncovering mechanisms of inflammation-associated colorectal carcinoma and in providing a novel conceptual framework for innate immune dysregulation in ulcerative colitis 19, 20 . Dysregulated tumour necrosis factor (TNF) production from colonic DCs underlies disease in TRUC mice as it causes epithelial cell apoptosis (FIG. 2) . In CD4 + T cells, T-bet transactivates Tnf, whereas in DCs, the Tnf locus is repressed by T-bet 21 . The generation of an isogenic colony of mice that did not develop colitis (TRnUC mice (Tbx21
−/− no ulcerative colitis)) enabled the identification of a crucial pathobiont, Helicobacter typhlonius. Metagenomic sequencing of the colonic microbiome from TRUC and TRnUC mice, combined with complementation and transmissibility studies, confirmed that H. typhlonius was responsible for the colitic phenotype of TRUC mice 22 .
T-bet in ILCs.
Innate lymphoid cells (ILCs) are a newly described type of cell that share many functional attributes with effector T cell subsets 23 . ILCs are important at mucosal sites, where they regulate epithelial homeostasis in relation to the intestinal microbiome, and they are dysregulated in inflammatory disease in both mice and humans 24, 25 . It is increasingly recognized that shared transcriptional mechanisms are conserved between ILCs and CD4 + T cells and that ILC subsets mirror their T H cell counterparts in terms of their cytokine-producing capabilities. Thus, group 1 ILCs express T-bet, group 2 ILCs express GATA3 and group 3 ILCs express RORγt 26 . Natural killer (NK) cells have also been classified as group 1 ILCs, but given that they have substantial differences to this cell type, they will be considered separately. ILCs express the IL-7 receptor (IL-7R) and CD90 (also known as THY1) and are negative for all lineage markers and antigen (B cell and T cell) receptors. ILCs are dependent on IL-7R signalling through the common cytokine receptor γ-chain (γ c ). ILC1s, which are another subset of group 1 ILCs, are positive for NK cell p46-related protein (NKp46; also known as NCR1), as are a subset of group 3 ILCs (NKp46 + ILC3s), which also express IL-23R 26 . The first description of a functional role for T-bet in ILC biology came from studies in the TRUC mouse model (FIG. 3) . Colitis in TRUC mice was abrogated by genetic or antibody-mediated depletion of ILCs. Furthermore, T-bet seemed to control the plasticity of RORγt + ILCs, by inducing IFNγ expression and (FIG. 2) . These effects were partly mediated through direct repression of IL-7R expression by T-bet 22 . As IL-7 has been shown to stabilize RORγt expression in ILCs 27 , this provides a potential mechanism for the reciprocal expression pattern of T-bet and RORγt (FIG. 2) . DC-derived TNF functioned with IL-23 to drive IL-17 production by ILCs; this indicates that there is a newly identified level of innate cellular crosstalk at the inflamed mucosal surface (FIG. 3) .
Other studies have shown that T-bet has a crucial role in the development and function of group 1 and 3 ILCs. The absence of T-bet was shown to result in a loss of NKp46 + ILC3s in the small intestine 28 . T-bet was found to be expressed in CC-chemokine receptor 6 (CCR6) − ILC3s but not in CCR6 + ILC3s. Within the T-bet
subset, both NKp46 + and NKp46 − ILC3s were identified, and T-bet expression was found to be increased in proportion to NKp46 expression, which also correlated with increasing IFNγ expression 29 . Other canonical T-bet target genes, such as CXC-chemokine receptor 3 (Cxcr3) and CD95 ligand (Cd95l; also known as Fasl) are also expressed in T-bet + CCR6
− ILC3s. The signals that regulate T-bet expression in ILC3s are incompletely defined; IL-12 was shown not to be required but IL-23 induced T-bet expression 29 . IFNγ-producing T-bet + ILC1 subsets have recently been reported in mice and humans and these cells were shown to accumulate in inflamed mucosal tissues of patients with Crohn's disease 24, 25 . Whether ILC1s represent a separate lineage or whether they are related to NK cells or ILC3s remains to be determined. In the absence of T-bet, susceptibility to metastatic cancer, including melanoma, was shown to be increased because of impaired NK cell function and survival in vivo 32 . T-bet deficiency alone only induces a partial defect in NK cell numbers as a result of a compensatory increase in EOMES, whereas deletion of both T-bet and EOMES results in a complete absence of NK cells 30 . The development of immature NK cells that express TNFrelated apoptosis-inducing ligand (TRAIL; also known as TNFSF10) was shown to be dependent on T-bet, whereas maturation and loss of TRAIL expression was shown to be more strongly influenced by EOMES 30 .
T-bet in non-conventional T cells. T-bet is also expressed in invariant NKT (iNKT) and γδ T cells. These thymusderived cells share features of both innate and adaptive immune cells and require T-bet either for their development (in the case of iNKT cells) or for their production of effector cytokines (in the case of γδ T cells). In the absence of T-bet, the number of Vα14i NKT cells is significantly reduced, possibly because of impaired survival that results from reduced IL-15R signalling secondary to low expression of the T-bet target gene Cd122 (also known as Il15rb) 31, 33 . Despite the marked reduction in numbers of iNKT cells in the absence of T-bet, the remaining iNKT cells were able to induce airway hyper-reactivity through their augmented IL-4 and IL-13 production 34 . T-bet is not expressed in naive γδ T cells but its expression is induced in γδ T cells following T cell receptor (TCR) signalling 35 (FIG. 2) . A high percentage of γδ T cells will produce IFNγ after TCR stimulation, and this is regulated by inducible T-bet and constitutive EOMES expression 36 . T-bet deficiency results in a 50% reduction in the frequency of IFNγ-producing γδ T cells, which suggests that constitutive EOMES expression and the hypomethylation of intron 1 at the Ifng locus contribute to the remaining IFNγ production by T-bet-deficient γδ T cells 36 .
T-bet in T H cells T-bet: the master regulator of T H 1 cell differentiation.
Selective expression of T-bet accounts for T H 1 cell development and for the T H 1 cell-specific expression of IFNγ 37 [37] [38] [39] [40] . Conversely, T-bet-deficient CD4 + T cells only produce small amounts of IFNγ under T H 1 cell-polarizing conditions and fail to mount effective T H 1 cell responses during infections with Leishmania major, Mycobacterium tuberculosis and Salmonella enterica subsp. enterica serovar Typhimurium [41] [42] [43] .
T-bet is not expressed in naive CD4
+ T cells, but is readily induced in response to TCR, IFNγ-STAT1 and IL-12R-STAT4 signalling pathways 37, [44] [45] [46] [47] . TCR and IFNγ receptor (IFNγR) signalling induce the first wave of T-bet expression, which is independent of IL-12R signalling that is caused by the TCR-mediated inhibition of expression of IL-12Rβ2 subunit [44] [45] [46] (FIG. 4) . Cessation of both TCR stimulation and IL-2R-STAT5 signalling induces IL-12Rβ2 subunit expression, which thus enables IL-12R signalling 46, 48 (FIG. 4) . IL-12 functions via STAT4 to induce a second wave of T-bet expression, which is required for the stabilization of the T H 1 cell phenotype 8, [45] [46] [47] . It is unclear whether imprinting of the T H 1 cell developmental programme involves autoactivation of the Tbx21 gene by T-bet. Ectopic expression of T-bet induces endogenous expression of Tbx21, which suggests that autoactivation occurs 4, 44, 45 . However, in one reported study, endogenous Tbx21 induction was dependent on autocrine IFNγR signalling 44 . The question of whether T-bet autoregulation occurs in developing T H 1 cells has been recently re-examined using T-bet-ZsGreen -reporter mice. In this study, it was shown that T-bet was not required for its own induction when IL-12 or IFNγ were present during differentiation; however, T-bet may be involved in directly promoting its own expression when induced by IL-12-and IFNγ-independent pathways 8 . Another level of complexity with regard to the regulation of T-bet expression in T H 1 cells has been added by the observations that T-bet expression in T H 1 cells is fine-tuned post-transcriptionally by the microRNA-29 cluster and post-translationally by the ubiquitin-proteasomal degradation pathway [49] [50] [51] . Together with STAT4, T-bet has a central role in the generation of transcriptionally competent T H 1 cell-specific genes in CD4 + T cells. The molecular mechanisms by which T-bet modifies chromatin state have recently been reviewed 52 and will be summarized here in general terms. T-bet-mediated chromatin changes are primarily dependent on the ability of T-bet to recruit enzymes that generate chromatin modifications associated with either gene activation (histone H3 or H4 acetylation, and H3 lysine 4 (H3K4) dimethylation) or gene repression (H3K27 trimethylation) 53, 54 . CD4 + T cells that have been polarized under T H 1 cell-associated conditions have increased expression of permissive marks at gene loci that are known to be positively regulated by T-bet. Conversely, genes that are normally repressed by T-bet in T H 1 cells are characterized by the presence of repressive H3K27 trimethylation marks 8, 47, [55] [56] [57] [58] ( FIG. 4) . High levels of Ifng transcription are subject to change in T H 1 cells depending on epigenetic modifications that remodel the Ifng locus; T-bet and STAT4 cooperate in this process 8, 47, 56 . T-bet directly activates the Ifng gene by binding to the Ifng promoter and to multiple distal regulatory elements located -54, -34, -22 and -6 kilobases (kb) upstream and +18-20 kb downstream of the Ifng gene, almost all of which serve as T-bet-dependent enhancers [56] [57] [58] . T-bet-mediated transactivation of the Ifng gene is further enhanced by H2.0-like homeobox protein (HLX) and runt-related transcription factor 3 (RUNX3) transcription factors, the expression of both of which is induced by T-bet in differentiating T H 1 cells 59, 60 . Another key regulatory role of T-bet is to organize the three-dimensional architecture of the Ifng locus by enhancing occupancy of the transcriptional repressor CCCTC-binding factor (CTCF) between the boundaries of the Ifng locus (-70 kb and +66 kb) and a +1 kb site. T-bet binding at these locations promotes CTCF-dependent chromatin looping, which brings T-bet-binding enhancers and CTCF-binding sites in close proximity at the Ifng promoter. This configuration promotes robust Ifng expression in T H 1 cells 61 . T-bet directly activates approximately 50% of T H 1 cell-specific genes including cytokines (for example, Ifng, lymphotoxin-α (Lta) and Tnf), chemokines (for example, XC-chemokine ligand 1 (Xcl1), CC-chemokine ligand 3 (Ccl3) and Ccl4) and chemokine receptors (Cxcr3 and Ccr5), which are required for the proper effector function and the migration of T H 1 cells, and for the recruitment of other immune cells to sites of inflammation 8, 21, 47, 62 (FIG. 4) . Although most of the T H 1 cell-specific gene expression is T-bet dependent, T-bet has limited effects in establishing global enhancer competence in T H 1 cells. This function has been attributed to STAT4, which has a major effect on the activation of T H 1 cell lineage-specific enhancers 5 . Reinforcement of the T H 1 cell differentiation programme relies not only on the T-bet-regulated activation of T H 1 cell-specific genes but also on the concomitant inhibition of alternative T H cell differentiation pathways. T-bet regulates this either by suppressing the induction of other lineage-specifying transcription factors in T H precursor cells or by interfering with their transcriptional activity (FIG. 4) . Thus, T-bet deficiency is often accompanied by increased production of T H 2 cell-specific or T H 17 cell-specific cytokines 38, 43 .
Inhibition of T H 2 cell lineage commitment.
In contrast to T-bet, GATA3, which is the master regulator of the T H 2 cell differentiation programme, is already expressed in naive CD4 + T cells 63 . Furthermore, activation of naive CD4 + T cells results in a transient, non-selective histone acetylation at both T H 1 cell-specific and T H 2 cell-specific cytokine genes, which persists for 17 to 20 hours after TCR stimulation 55 . It is at these early stages of T H cell lineage commitment that T-bet must compete with
Box 1 | CD4 + T H subsets
When a naive CD4 + T cell gets activated by an antigen-presenting cell (APC) in the periphery, it differentiates into one of several T helper (T H ) cell subsets to become a T H 1, T H 2, T H 17, T follicular helper (T FH ) or peripherally derived regulatory T (pT Reg ) cell. The decision-making process is instructed by the cytokines that are present in the environment during the activation process. Each T H cell subset is distinguished by a specialized gene expression programme, which is under the control of a lineage-defining transcription factor. The lineage-defining transcription factors are T-bet for the T H 1 cell lineage, GATA-binding protein 3 (GATA3) for the T H 2 cell lineage, retinoic acid receptor-related orphan receptor-γt (RORγt) for the T H 17 cell lineage, B cell lymphoma-6 (BCL-6) for T FH cells and forkhead box P3 (FOXP3) for pT Reg cells (see the figure). CD4
+ T H cell subsets are defined by the signature cytokines that they express, their distinct homing properties and their specialized effector functions, which make them best equipped to target a particular class of pathogen. Thus, T H 1 cells produce interferon-γ (IFNγ) and are particularly effective at activating macrophage microbicidal mechanisms against intracellular bacteria, protozoa and viruses. 
T-bet Ifng
Tbx21 GATA3 to establish a T H 1 cell-specific gene expression programme. Early TCR signalling induces T-bet expression, and IL-2-inducible T cell kinase (ITK)-mediated phosphorylation of T-bet at Tyr525 promotes the interaction of T-bet with GATA3 (REF. 64 ). This interaction redistributes GATA3 away from T H 2 cell-specific genes to T-bet-binding sites at T H 1 cell-specific loci 4, 64 . Sequestration of GATA3 away from T H 2 cell-specific genes (primarily the Il4-Il5-Il13 locus) and the binding of a T-bet-RUNX3 complex to the Il4 silencer (DNase I hypersensitivity site 4 (HS4)) prevents the expression of T H 2 cell-specifc cytokine genes in developing T H 1 cells 4, 60, 64 (FIG. 4) . Furthermore, T-bet binds to and promotes repressive chromatin modifications at the Gata3 locus, which thus inhibits the de novo expression of Gata3 in T H 1 cells 8 . In addition to GATA3, nuclear factor of activated T cells 1 (NFAT1; also known as NFATC2) promotes T H 2 cell differentiation through the activation of Il2, Il4, Il5 and Il13. T-bet phosphorylation at Thr302 is crucial for the inter action of T-bet with NFAT1 and loss of this interaction through mutation of the Thr302 residue abrogates the ability of T-bet to suppress NFAT1-dependent IL-2 and T H 2-type cytokine expression 51 . T-bet can also limit IL-2 production by 
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Mice with a spontaneous mutation in forkhead box P3 (Foxp3), which leads to a rapidly fatal lymphoproliferative disease, causing death by ~4 weeks of age.
suppressing RELA activity through serine phosphorylation. T-bet phosphorylation at Ser508 by casein kinase I and glycogen synthase kinase 3 (GSK3) kinases promotes the interaction of T-bet with RELA, which impairs RELA binding to the Il2 promoter and the subsequent transcriptional activation of the Il2 gene by RELA 65 . Since IL-2 is required for upregulation of the IL-4Rα subunit, the negative regulatory effects of T-bet on Il2 gene expression efficiently limit IL-4 signalling and T H 2 cell differentiation.
T-bet can also override a previously programmed T H 2 cell differentiation state. Lymphocytic choriomeningitis virus (LCMV) infection, as well as a combination of type I or type II interferons and IL-12 in vitro, has been shown to reprogramme committed T H 2 cells into T H 1-like T H 2 cells. These cells co-express GATA3 and T-bet and they produce T H 1-and T H 2-type cytokines following reactivation 66 . The conversion of T H 2 cells into T H 1-like cells was shown to be entirely dependent on T-bet both in vitro and in vivo. Sequential acquisition of T-bet and its downstream differentiation programme without extinguishing the previously acquired T H 2 cell differentiation programme produced a population of optimally adapted T H cells, which were highly effective against LCMV but which protected tissues against immune-mediated pathology 66 . 67, [71] [72] [73] . In addition to T-bet upregulation, the conversion of T H 17 cells into T H 1-like cells is accompanied by the downregulation of RORγt and T H 17 cell-specific cytokines 38, 72 (FIG. 4) . Silencing of Rorc in committed T H 17 cells following IL-12R signalling has been linked with STAT4-induced and T-bet-induced epigenetic repression of the Rorc gene 72 . This is in contrast to what has been observed in T H 2 cells, in which T-bet induction did not result in silencing of GATA3 expression. Although it is possible for opposing transcription factors to be present in the same cell during transitions, termination of Rorc expression in T H 17 cells during conversion into T H 1-like cells could reflect a greater susceptibility of the Rorc locus to epigenetic remodelling by T-bet and STAT4 transcription factors 72 .
Inhibition of T H 17 cell lineage commitment. T-bet expression in T H precursor cells inhibits commitment
Inhibition of T FH cell lineage commitment. The early steps in T H 1 cell commitment have many features in common with the T follicular helper (T FH ) cell differentiation pathway 74 . IL-12 signals through STAT4 to induce a transitional stage of T FH cell-like T H 1 cells, which express IL-21 and B cell lymphoma 6 (BCL-6). However, these T FH cell-like features are not sustained, as STAT4 also promotes T-bet expression, which inhibits the induction of T FH cell-specific genes by limiting the expression of BCL-6. Interestingly, the Bcl6 locus is not fully repressed in differentiated T H 1 cells 74 . In fact, the low concentrations of BCL-6 that are present in T H 1 cells are necessary for T-bet to effectively repress alternative T H cell gene programmes. T-bet interacts with BCL-6 and recruits it to the promoters of genes that are repressed by T-bet in T H 1 cells 75 . When the concentrations of BCL-6 are low, T-bet sequesters BCL-6 away from its target genes, which thereby effectively blocks T FH cell lineage commitment (FIG. 4) . The primary determinant of the relative ratio of T-bet to BCL-6 in T H 1 cells is the concentration of IL-2 (REF. 76 ). In the presence of high levels of IL-2, the levels of BCL-6 are kept low. However, in low IL-2 concentrations, forkhead box O (FOXO) transcription factors induce BCL-6 and tip the balance in favour of expression of BCL-6 and the T FH cell gene expression profile. Thus, low doses of IL-2R signalling can change polarized T H 1 cells into T FH cells, which suggests that T H 1 cells retain a great degree of flexibility and have a T FH cell-like gene profile 76 . Similarly, T FH cells can acquire the properties of T H 1 cells after exposure to T H 1 cellpolarizing cytokines 77 . T FH cells have positive chromatin modifications at the Tbx21 locus, which maintains this gene in a state that is primed for re-expression. T-bet expression endows T FH cells with the ability to produce IFNγ without affecting their ability to produce IL-21 and to express T FH cell-specific markers 77 .
Peripherally derived T Reg cells.
Similarly to what was observed in other T H cell subsets, in peripherally derived regulatory T (pT Reg ) cells (also known as induced or adaptive T Reg cells) the Tbx21 locus is maintained in an open conformation and T-bet is upregulated in response to STAT1-mediated IFNγR and IL-27R signalling 73, [78] [79] [80] . T-bet-deficient pT Reg cells do not survive well after adoptive transfer into scurfy mice and fail to protect the mice from T H 1 cell-mediated inflammatory responses. This suggests that T-bet is required for the functional fitness of pT Reg cells 80 . It is incompletely understood how T-bet controls pT Reg cell function and it is equally intriguing how pT Reg cells maintain a FOXP3-regulated gene expression profile in the presence of T-bet. As adoptive transfers of pT Reg cells have been considered as a potential therapy for inflammatory and autoimmune diseases, the plasticity of the pT Reg cell transcriptional programme has gained increasing attention. There is the possibility that a pT Reg cell could gain the effector profile of a T H 1 cell in a dominating T H 1 cell-associated environment. A recent study showed that T-bet + pT Reg cells express 10-20-fold less T-bet than conventional T H 1 cells even in T H 1-type inflammatory conditions 80 . The low level of T-bet expression in pT Reg cells is maintained by the silencing of the Il12rb2 locus, which prevents T-bet + pT Reg cells from completing IL-12R-STAT4-dependent T H 1 cell differentiation. This maintains the suppressive function of these cells without the production of proinflammatory cytokines 79 . However, T-bet expression in pT Reg is absolutely essential for their proper migration. T-bet induces the expression of CXCR3 -a T H 1 cellassociated chemokine receptor -which enables T-bet + pT Reg cells to migrate to sites of T H 1 cell-mediated inflammation and to suppress local T H 1 cell responses. Although Tbx21 encodes the T H 1 cell lineagespecifying transcription factor, the promoter of the Tbx21 gene is marked by permissive and repressive genetic marks in T H 2, T H 17, T FH and pT Reg cells, and it is poised for subsequent activation or silencing 71, 73, 77 . Maintenance of the master transcription factor loci in a poised, bivalent epigenetic state in the opposing T H cell subsets is the basis for functional plasticity of CD4 + T H cells, which respond to changes in the environment by adopting the gene expression profiles of other T H cell lineages 73 . T-bet has a dominant role, often tipping the balance towards a T H 1 cell phenotype. As described in the aforementioned examples, sometimes the acquisition of T H 1 cell properties is accompanied by the repression of the existing gene expression profile (in the case of T H 17 cells). In other cases, the responding T H cell subset gains features of the T H 1 cell lineage, such as IFNγ and CXCR3 expression, but keeps its genetic profile (in the case of T H 2, T FH and pT Reg cells). Functional plasticity of CD4 + T H cells could be one mechanism to provide maximum host protection by generating large numbers of T H 1 cells from pre-existing T H cell subsets following infection with intracellular pathogens. However, in the case of pT Reg cells, increased T-bet expression is required for proper migration of pT Reg cells to sites of T H 1-cell dominated responses to minimize the amount of immune-mediated pathology.
Generation of B cell and T cell memory T-bet in CD8
+ T cell memory. The acquisition of CD8 + T cell effector functions and the development of CD8 + T cell memory (BOX 2) are crucially dependent on transcriptional events that are regulated by T-bet and EOMES. CD8 + T cells that lack either T-bet or EOMES show a minor defect in their effector functions, which suggests that these two transcription factors have overlapping and partially redundant roles in establishing the differentiation programme of CD8 + T cells 81, 82 . However, CD8 + T cells that are deficient in both T-bet and EOMES lose their cytotoxicity and aberrantly produce large amounts of IL-17A in response to infection with LCMV 83 . T-bet expression is rapidly induced by TCR and IL-12R signalling, and is required for the early production of IFNγ and granzyme B (encoded by Gzmb) by antigen-specific CD8 + T cells 84, 85 (FIG. 5) .
EOMES, which is induced later in a RUNX3-dependent manner, can substitute for T-bet to promote IFNγ and granzyme B expression and, together with STAT5, regulates perforin gene expression in CD8 + T cells 84, 86 ( FIG. 5a) . The concerted action of T-bet and EOMES results in the development of fully differentiated effector CD8 + T cells that migrate to inflamed tissues and that, following antigen recognition, secrete cytokines (for example, IFNγ and TNF) or lyse infected cells by releasing cytotoxic granules that contain granzymes and perforin.
T-bet and EOMES have essential but reciprocal roles in regulating effector and memory T cell differentiation pathways [87] [88] [89] FIG. 5b) . Inflammatory signals that are present during CD8 + T cell priming define a gradient of T-bet and EOMES expression and, consequently, influence the fate of effector CD8 + T cells 87 . Strong IL-12R signalling provides the instructive signal for the terminal differentiation of short-lived effector cells (SLECs) by enhancing and maintaining STAT4-mediated mammalian target of rapamycin (mTOR) kinase activity. This functions as a molecular switch to concomitantly induce T-bet expression and to repress EOMES expression through the inhibition of FOXO1 transcriptional activity 85, 88, 89 . Thus, T-bet deficiency, IL-12 deficiency or inhibition of mTOR activity results in a profound absence of SLECs and in the Box 2 | CD8 + T cell memory
When a naive CD8 + T cell encounters an antigen, it undergoes a differentiation programme that can be divided into three main developmental stages: clonal expansion and differentiation, contraction, and memory formation. The differentiation process that occurs at the peak of the response generates quite a heterogeneous population of CD8 + T cells, which have different fates and memory cell developmental potential. Short-lived effector cells (SLECs) are terminally differentiated effector cells that express low levels of interleukin-7 receptor-α (IL-7Rα) and high levels of killer cell lectin-like receptor subfamily G member 1 (KLRG1) and IL-2Rα. By contrast, memory precursor effector cells (MPECs), which give rise to long-lived, self-renewing memory CD8 + T cells, express high levels of IL-7Rα and low levels of KLRG1 and IL-2Rα. After an infection is cleared, the vast majority of antigen-specific CD8 + T cells that are generated during clonal expansion die. The cells that survive the contraction phase, the MPECs, go on to generate a reservoir of memory CD8 + T cells. Memory T cells can be either effector memory (T EM ) accumulation of long-lived memory precursor effector cells (MPECs) 87, 89 (FIG. 5b) . In addition to cytokine signalling, asymmetric partitioning of key transcriptional regulators, such as T-bet, between the daughter cells during cell division may regulate the SLEC versus MPEC fate decision 90 . The cell that acquires more T-bet during cell division becomes a terminally differentiated effector cell, whereas the cell that has low T-bet levels has a higher memory cell developmental potential 90 . Once the pathogen is cleared, the vast majority of antigen-specific CD8 + T cells that are generated during clonal expansion die. A small fraction of CD8 + T cells that survive the contraction phase, the MPECs, generate a reservoir of memory CD8 + T cells, which depend on the cytokines IL-7 and IL-15 for their long-term persistence
. As CD8 + T cells acquire a memory phenotype, EOMES expression increases whereas T-bet levels decrease [91] [92] [93] (FIG. 5c) . Nevertheless, low levels of T-bet are maintained in memory CD8 + T cells, and T-bet and EOMES cooperate to sustain proper expression of CD122 (the β-subunit of IL-2R and IL-15R) to promote the longevity and the homeostatic proliferation of memory CD8 + T cells 94 . Effector memory T (T EM ) cells express higher levels of T-bet and seem to be more differentiated than central memory T (T CM ) cells 92 . By contrast, the expression of EOMES is higher in T CM cells than in T EM cells 91, 92 (FIG. 5c) . EOMESdeficient memory CD8 + T cells are less efficient at competing to populate the bone marrow niche and are defective in long-term persistence and secondary expansion after antigen re-challenge 92 . These findings suggest that EOMES expression is needed for the competitive fitness and the persistence of T CM cells, whereas T-bet expression is associated with a more differentiated phenotype of T EM cells.
Subsequent antigen encounters or the exposure of memory CD8 + T cells to inflammatory cytokines leads to a rapid upregulation of T-bet and to the terminal differentiation of memory CD8 + T cells during secondary and tertiary infections 91 (FIG. 5c) . Limited T-bet expression in Tbx21 +/− CD8 + T cells enables memory CD8 + T cells to retain a less differentiated state during multiple rounds of antigen re-challenge, which thereby prevents the senescence of memory CD8 + T cells 91 . Furthermore, memory CD8 + T cells that develop in the absence of CD4 + T cell help seem to be more T EM cell-like, as they are characterized by elevated T-bet levels. In these cases, T-bet deletion has been found to prevent the aberrant differentiation of 'unhelped' memory CD8 + T cells 93 . Therefore, it may be possible to minimize terminal differentiation of secondary and tertiary memory CD8 + T cells and to correct the dysfunctional programming of CD8 + T cells that develop in the absence of CD4 + T cell help simply by limiting T-bet expression 91, 93 .
During chronic infections, CD8
+ T cell responses are quite different from those observed during acute infections. When they are exposed to persistent antigenic stimulation, CD8 + T cells become dysfunctional, exhausted and fail to differentiate into effective memory CD8 + T cells. The exhaustion of CD8 + T cells is accompanied by the upregulation of inhibitory molecules (such as programmed cell death protein 1 (PD1; encoded by Pdcd1), lymphocyte activation gene 3 protein (LAG3) and B-and T-lymphocyte attenuator (BTLA)), as well as defective proliferation, cytokine production and cytotoxicity in these cells 95, 96 . In this context, elevated T-bet levels improve the functionality and the long-term durability of antigen-specific CD8 + T cells, whereas EOMES expression enhances CD8 + T cell exhaustion 97, 98 . T-bet represses the expression of inhibitory receptors, including PD1, and improves the fitness of exhausted CD8 + T cells 97 . Thus, therapeutic strategies that aim to increase T-bet expression in CD8 + cells could minimize CD8 + T cell exhaustion and improve CD8 + T cell responses during chronic infections 97 . Collectively, these studies show the complex regulation of T-bet and EOMES expression that takes place during acutely resolved versus chronic infections. Our understanding of the differentiation pathways that are regulated by T-bet and EOMES will provide novel ideas for therapeutic interventions and will improve the efficacy of memory CD8 + T cell responses in the context of acute and chronic infections.
T-bet in CD4
+ T cell memory. Unlike the formation of CD8 + T cell memory, which has been intensely studied over many years, very little is known about the requirements for the formation, the proper function and the maintenance of CD4 + T cell memory. Similarly to CD8 + T cell responses, there is marked phenotypic heterogeneity in the antigen-specific CD4 + T cells at the peak of the response. However, the particular features that distinguish a population of committed memory precursor cells from the larger pool of diverse effector cells remain a matter of debate. Infection with intracellular bacteria or viruses induces the formation of both T H 1 cells and T FH cells, and these effector CD4 + T cell subsets can be readily distinguished by their differential expression of CXCR5, P-selectin glycoprotein ligand 1 (PSGL1) and LY6C (FIG. 5d) low memory compartment, which persists longer and proliferates better than the LY6C hi subset following antigen rechallenge 99 . Similarly to antigen-specific CD8 + T cells, elevated T-bet expression is required for maximal clonal expansion and for the formation of terminally differentiated PSGL1
hi LY6C hi CD4 + T cells. Loss of one or two copies of T-bet results in a proportionally increased frequency of PSGL1 hi LY6C low T H 1 memory precursor cells 99 . Thus, T-bet balances terminal differentiation and memory cell potential in both CD4
+ and CD8 + T cells 99 .
Affinity maturation
The process by which B cells produce antibodies that have an increased affinity for antigens during an immune response.
Class-switch recombination [99] [100] [101] . Furthermore, T FH cells maintain repressive methylation of the granzyme B locus throughout effector and memory cell differentiation. They also produce limited amounts of IFNγ following reinfection with LCMV [99] [100] [101] . Silencing of the Gzmb locus and other T H 1 cell-specific loci in T FH memory cells reinforces the T FH cell-lineage programme and prevents the expression of T H 1 cell-specific genes following acute LCMV infection 100 . In contrast to these findings, CXCR5 T-bet low cells, which give rise to T CM cells. In the second example, the balance between T-bet and BCL-6 would be a principal mechanism regulating the generation of distinct memory cell populations 100, 101 .
T-bet in B cell memory. In response to antigen stimulation, activated B cells proliferate and undergo affinity maturation and class-switch recombination (CSR) in order to produce high-affinity antibodies that have different immune effector functions. IgG2a is the most prevalent isotype that is produced in response to intracellular bacterial and viral infections. Cytokines such as IFNγ and IL-27 increase T-bet expression in B cells in a STAT1-dependent and ETS1-dependent manner [102] [103] [104] [105] (FIG. 5e) . T-bet subsequently induces the expression of Iγ2a transcripts and promotes IFNγ-mediated classswitching to the IgG2a isotype 103 . T-bet-deficient B cells show impaired IgG2a, IgG2b and IgG3 secretion. In addition, ectopic expression of T-bet is sufficient to induce the expression of germline Iγ2a transcripts in Tbx21 −/− B cells even in the absence of IFNγR signalling 103 . T-bet expression persists in antigen-specific IgG2a + CD38
hi memory B cells and it promotes the survival of this cell subset by regulating the transcription of the mature B cell receptor 106 . Furthermore, T-bet drives the migration of memory IgG2a + B cells to sites of inflammation by controlling the expression of the chemokine receptor CXCR3 (REF. 107 ).These findings identify T-bet as a selective inducer of IFNγ-mediated IgG2a class-switching in B cells and a key regulator of B cell migration to inflammatory foci.
Conclusions and perspectives
T-bet has important roles in multiple aspects of a coordinated immune response. It regulates the development of components of the innate immune system, it affects the trafficking of both innate and adaptive immune cells and it controls the polarity of cytokine responses. In this way, T-bet functions as the key molecule in coordinating effective and anatomically appropriate type 1 immunity. Despite the intensive studies that have been ongoing for over a decade, much still remains to be learned about the cell-specific roles of T-bet. Indeed, the recent descriptions of the role of T-bet in the newly discovered ILCs have highlighted further functions of this protean transcription factor. There is still much to be learned about the upstream signals that regulate T-bet expression in specific cell types and how T-bet interacts with other lineage-determining transcription factors in vivo. It is tempting to speculate that modulation of T-bet expression may be a very powerful therapeutic target for the treatment of autoimmunity, transplant rejection, infectious diseases and cancer in the not too distant future.
